Trial Profile
Effect of add-on medication (with dose increase, combined with anti-leukotriene, combined with steroid nasal spray) for allergic rhinitis patients who are not effective of normal dose of Bepotastine besilate.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 09 Aug 2016
Price :
$35
*
At a glance
- Drugs Bepotastine (Primary) ; Leukotriene inhibitors; Steroids
- Indications Allergic rhinitis
- Focus Therapeutic Use
- 04 Aug 2016 Status changed from not yet recruiting to discontinued.
- 06 Oct 2013 New trial record